Virbac is delighted to announce the launch of Speed Reader, a compact and intuitive laser-induced fluorescent reader that measures the concentration of biomarkers in serum and plasma, offering an efficient and affordable solution to expand in-clinic diagnostic services.
Complemented by biomarker tests for T4, Cortisol, CPSE, Progesterone and cCRP, Speed Reader is unique in that it is the ONLY in-clinic diagnostic biomarker test for CPSE, to screen dogs for Benign Prostatic Hyperplasia, of which 80% of intact male dogs over the age of 5 years old are at risk of developing (1,2).
Speed Reader provides practices with the opportunity to increase in-clinic diagnostic testing, reducing reliance on external laboratories, delivering immediate results and improving profitability. Offered with an intuitive touch screen user interface and integrated printer, Speed Reader tests can be performed in as little as 15 minutes using a simple step-by-step procedure displayed on the touch screen.
‘The Speed Reader biomarker range is a fantastic addition to Virbac’s diagnostic portfolio’ said Andrew Connolly, Head of Marketing – Companion Animals at Virbac. ‘Not only does Speed Reader offer practices improved in-clinic diagnostic testing, but having listened to customer feedback we are also offering Speed Reader with transparent, straightforward pricing and without complex commitment contracts.’